David Champion, MD
Family Medicine · Brownsville, TXNPI 1326046004
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,280 of the $11,734 with a category attached, or 96.1%. CSL Plasma Inc. accounts for 96.1% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $7,520 and has fallen 98.4% since, to $120 in 2025. Among family medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 32 payments — averaging $366.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Plasma Inc.$11K
- Alkermes, Inc.$97
- Otsuka America Pharmaceutical, Inc.$91
- Teva Pharmaceuticals USA, Inc.$67
- Neurocrine Biosciences, Inc.$51
- Vanda Pharmaceuticals Inc.$26
- plus $123 from 7 others
What the payments were for
- Consulting fees$11,28096%
- Food & beverage$4544%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$11,734 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 43 | $45,880 |
| FarxigaDapagliflozin Propanediol | 32 | $32,337 |
| JanuviaSitagliptin Phosphate | 29 | $28,050 |
| TrulicityDulaglutide | 13 | $14,090 |
| Metformin Hcl | 99 | $1,304 |
| Atorvastatin Calcium | 82 | $1,017 |
| FenofibrateFenofibrate Nanocrystallized | 20 | $896 |
| Rosuvastatin Calcium | 52 | $831 |
| Glipizide | 36 | $786 |
| Tolterodine Tartrate ErTolterodine Tartrate | 14 | $700 |
| Lisinopril | 63 | $543 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 33 | $526 |
| Glipizide ErGlipizide | 21 | $512 |
| Losartan Potassium | 26 | $494 |
| Pioglitazone Hcl | 16 | $451 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Brownsville
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.